Flow Traders U.S.’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,615
Closed -$260K 1079
2025
Q1
$260K Buy
+11,615
New +$290K 0.01% 768
2024
Q4
Sell
-9,762
Closed -$244K 1133
2024
Q3
$244K Sell
9,762
-7,609
-44% -$191K 0.01% 737
2024
Q2
$410K Buy
17,371
+7,749
+81% +$184K 0.02% 596
2024
Q1
$246K Sell
9,622
-6,556
-41% -$169K 0.01% 612
2023
Q4
$424K Sell
16,178
-4,025
-20% -$87.4K 0.01% 532
2023
Q3
$424K Sell
20,203
-12,619
-38% -$293K 0.02% 518
2023
Q2
$798K Sell
32,822
-4,371
-12% -$109K 0.03% 387
2023
Q1
$887K Buy
37,193
+3,130
+9% +$79.7K 0.04% 354
2022
Q4
$886K Sell
34,063
-12,908
-27% -$328K 0.04% 324
2022
Q3
$1.17M Buy
+46,971
New +$1.14M 0.06% 286

Other funds holding IBRN

Flow Traders U.S.'s IBRN Position: Q2 2025 in Review

Flow Traders U.S. sold out of iShares Neuroscience and Healthcare ETF (IBRN) in Q2 2025, closing a stake of 11,615 shares — an estimated $260K sold.

Flow Traders U.S. first reported a position in IBRN in Q3 2022 and held it in 10 quarters. The position peaked at $1.17M in Q3 2022. 4 funds tracked by Wall St. Rank hold IBRN as of Q2 2025.

  • Flow Traders U.S. reported no remaining iShares Neuroscience and Healthcare ETF position as of Q2 2025 after selling out during the quarter.
  • Flow Traders U.S. sold 11,615 iShares Neuroscience and Healthcare ETF shares in Q2 2025, an estimated $260K.
  • Flow Traders U.S. first reported a position in iShares Neuroscience and Healthcare ETF in Q3 2022 and held it in 10 quarters.
  • Flow Traders U.S.'s iShares Neuroscience and Healthcare ETF position peaked at $1.17M in Q3 2022.
  • 4 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q2 2025.

Based on Flow Traders U.S.'s 13F filing for Q2 2025, filed 13 Aug 2025.